FDA oversight of laboratory-developed tests where are we now?

Ken Gatter

doi:10.5858/arpa.2017-0053-ED

FDA oversight of laboratory-developed tests where are we now?

Ken Gatter

Pathology

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	746-748
Number of pages	3
Journal	Archives of Pathology and Laboratory Medicine
Volume	141
Issue number	6
DOIs	https://doi.org/10.5858/arpa.2017-0053-ED
State	Published - Jun 2017

ASJC Scopus subject areas

Pathology and Forensic Medicine
Medical Laboratory Technology

Access to Document

10.5858/arpa.2017-0053-ED

Cite this

@article{09f747e5a8374b6ba278dd62a62f8599,

title = "FDA oversight of laboratory-developed tests where are we now?",

author = "Ken Gatter",

year = "2017",

month = jun,

doi = "10.5858/arpa.2017-0053-ED",

language = "English (US)",

volume = "141",

pages = "746--748",

journal = "Archives of Pathology and Laboratory Medicine",

issn = "0003-9985",